{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:23:56Z","timestamp":1778682236215,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013003","name":"University of Cagliari","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013003","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bioorg.2018.02.021","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T02:45:31Z","timestamp":1519353931000},"page":"633-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Alessio","family":"Nocentini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Moi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4437-6096","authenticated-orcid":false,"given":"Gianfranco","family":"Balboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severo","family":"Salvadori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-702X","authenticated-orcid":false,"given":"Valentina","family":"Onnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.02.021_b0005","first-page":"422","article-title":"Cyclooxygenase inhibitors: From pharmacology to clinical read-outs","volume":"2015","author":"Patrignani","year":"1851","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2018.02.021_b0010","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.2174\/0929867322666150716113501","article-title":"Dual cyclooxygenase and carbonic anhydrase inhibition by nonsteroidal anti-inflammatory drugs for the treatment of cancer","volume":"22","author":"De Monte","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_b0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2174\/1389557043403792","article-title":"COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents","volume":"4","author":"Supuran","year":"2004","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_b0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bmcl.2005.09.040","article-title":"Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II \u201cselective\u201d inhibitor celecoxib","volume":"16","author":"Di Fiore","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.02.021_b0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.bioorg.2018.02.021_b0030","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2018.02.021_b0035","series-title":"Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications","author":"Supuran","year":"2009"},{"key":"10.1016\/j.bioorg.2018.02.021_b0040","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2018.02.021_h0045","first-page":"404","article-title":"Carbonic anhydrase IX: biochemical and crystallographic characterization of a novel antitumor target","volume":"2010","author":"De Simone","year":"1804","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2018.02.021_h0050","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/acsmedchemlett.7b00399","article-title":"Discovery of new sulfonamide carbonic anhydrase IX inhibitors incorporating nitrogenous bases","volume":"8","author":"Nocentini","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.02.021_b0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2018.02.021_b0055","doi-asserted-by":"crossref","unstructured":"(a) F. Pacchiano, F. Carta, P.C. McDonald, Y. Lou, D. Vullo, A. Scozzafava, S. Dedhar, C.T. Supuran, Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis. J. Med. Chem. 54 (2011) 1896\u22121902; (b) ClinicalTrials.gov,https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02215850?term=SLC_0111&rank=1; (c) R.G. Gieling, M. Babur, L. Mamnani, N. Burrows, B.A. Telfer, F. Carta, J.-Y. Winum, A. Scozzafava, C.T. Supuran, K.J. Williams. Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts. J. Med. Chem. 55 (2012) 5591\u2013600.","DOI":"10.1021\/jm101541x"},{"key":"10.1016\/j.bioorg.2018.02.021_h0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/107327480200902S04","article-title":"Celecoxib: a specific COX-2 inhibitor with anticancer properties","volume":"9","author":"Koki","year":"2002","journal-title":"Cancer Control."},{"key":"10.1016\/j.bioorg.2018.02.021_h0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1475-2867-12-53","article-title":"Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo","volume":"12","author":"Dai","year":"2012","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bioorg.2018.02.021_h0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1756-9966-27-66","article-title":"Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2","volume":"27","author":"Park","year":"2008","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2018.02.021_b0065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2174\/138161208783877956","article-title":"Anticonvulsant sulfonamides\/ sulfamates\/sulfamides with carbonic anhydrase inhibitory activity: drug design and mechanism of action","volume":"14","author":"Thiry","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2018.02.021_b0070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1389557511313060012","article-title":"Pyrazolines: a biological review","volume":"13","author":"Marella","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0090","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1016\/j.ejmech.2011.08.015","article-title":"Synthesis and biological evaluation of some new 2-pyrazolines bearing benzene sulfonamide moiety as potential anti-inflammatory and anti-cancer agents","volume":"46","author":"Bano","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0095","article-title":"Anticancer agents that induce cell cycle arrest and apoptosis","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2018.02.021_h0100","doi-asserted-by":"crossref","first-page":"9153","DOI":"10.1038\/s41598-017-09655-7","article-title":"BHX, a novel pyrazoline derivative, inhibits breast cancer cell invasion by reversing the epithelial-mesenchymal transition and down-regulating Wnt\/\u03b2-catenin signalling","volume":"7","author":"Bao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2018.02.021_b0080","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3390\/molecules20022668","article-title":"\u00d6zkay, G. Turan-Zitouni. Synthesis and evaluation of new 1,5-diaryl-3-[4-(methyl-sulfonyl)phenyl]-4,5-dihydro-1H-pyrazole derivatives as potential antidepressant agents","volume":"20","author":"\u00d6zdemir","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2018.02.021_b0085","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejmech.2016.02.016","article-title":"Novel morpholinoquinoline nucleus clubbed with pyrazoline scaffolds: synthesis, antibacterial, antitubercular and antimalarial activities","volume":"112","author":"Karad","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0115","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejmech.2016.07.055","article-title":"4, 5-Dihydrooxazole-pyrazoline hybrids: synthesis and their evaluation as potential antimalarial agents","volume":"123","author":"Pandey","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/14756366.2016.1243534","article-title":"Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (AChE) and buthylcholinesterase (BuChE) inhibitors: the influence of chlorine, alkyl amine side chain and \u03b1, \u03b2-unsaturated ketone group","volume":"32","author":"Gao","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_b0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/acsmedchemlett.5b00326","article-title":"Monoamine oxidase inhibitory activity of novel pyrazoline analogues: curcumin based design and synthesis","volume":"7","author":"Badavath","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.02.021_h0130","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.bmc.2016.03.032","article-title":"Synthesis, anti-inflammatory, analgesic, COX-1\/2 inhibition activities and molecular docking study of pyrazoline derivatives","volume":"24","author":"Abdel-Sayed","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0135","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1016\/j.bmcl.2017.06.063","article-title":"Synthesis of novel 2-pyrazoline analogues with potent anti-inflammatory effect mediated by inhibition of phospholipase A2: crystallographic, in silico docking and QSAR analysis","volume":"27","author":"Lokeshwari","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.02.021_b0105","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1089\/neu.2015.4079","article-title":"Neuroprotective Effects of the Glutamate Transporter Activator (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153) following Traumatic Brain Injury in the Adult Rat","volume":"33","author":"Karklin Fontana","year":"2016","journal-title":"J. Neurotrauma."},{"key":"10.1016\/j.bioorg.2018.02.021_h0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/14756366.2016.1217852","article-title":"Synthesis, cytotoxicity and carbonic anhydrase inhibitory activities of new pyrazolines","volume":"31","author":"Kucukoglu","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0150","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3109\/14756366.2016.1160077","article-title":"Synthesis and bioactivity studies on new 4-(3-(4-Substitutedphenyl)-3a,4-dihydro-3H-indeno[1,2-c]pyrazol-2-yl) benzenesulfonamides","volume":"31","author":"Gul","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756366.2016.1181627","article-title":"C.T. Supuran. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides","volume":"31","author":"Mete","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14756366.2016.1244533","article-title":"Synthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines","volume":"32","author":"Gul","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0165","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bmcl.2015.12.016","article-title":"Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors","volume":"26","author":"Yaseen","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.02.021_h0170","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4155\/fmc.14.68","article-title":"Sulfonamides and their isosters as carbonic anhydrase inhibitors","volume":"6","author":"Carta","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0175","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.1016\/j.bmc.2015.07.024","article-title":"Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties","volume":"23","author":"Congiu","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0180","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1016\/j.bmcl.2012.05.083","article-title":"Ureido-substituted sulfamates show potent carbonic anhydrase IX inhibitory and antiproliferative activities against breast cancer cell lines","volume":"22","author":"Winum","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.02.021_h0185","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1021\/jm00169a021","article-title":"Chalcones: a new class of antimitotic agents","volume":"33","author":"Edwards","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0190","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0223-5234(02)01387-9","article-title":"Synthesis and inhibitory activity of dimethylamino-chalcone derivatives on the induction of nitric oxide synthase","volume":"37","author":"Rojas","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0195","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1016\/j.bmcl.2016.11.017","article-title":"Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides","volume":"26","author":"Arslan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.02.021_b0125","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.1016\/j.bmc.2010.07.037","article-title":"Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives","volume":"18","author":"Congiu","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_b0130","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_b0135","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1016\/j.bmcl.2005.05.067","article-title":"Synthesis of some pyrazole derivatives and preliminary investigation of their affinity binding to P-glycoprotein","volume":"15","author":"Manna","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.02.021_b0140","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1021\/jm031042b","article-title":"Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase","volume":"47","author":"Chimenti","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0220","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.bmc.2017.03.063","article-title":"Synthesis and biological evaluation of novel aromatic and heterocyclic bis-sulfonamide Schiff bases as carbonic anhydrase I, II, VII and IX inhibitors","volume":"25","author":"Akocak","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0225","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejmech.2017.01.017","volume":"127","author":"Eldehna","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0230","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.bmc.2016.12.040","article-title":"Dithiocarbamates effectively inhibit the \u03b2-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa","volume":"25","author":"Vullo","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0235","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm9900523","article-title":"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: Is the tail more important than the ring?","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J. Med. Chem"},{"key":"10.1016\/j.bioorg.2018.02.021_h0240","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0245","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.bmc.2017.01.008","article-title":"Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties","volume":"25","author":"Altug","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0250","doi-asserted-by":"crossref","first-page":"10692","DOI":"10.1021\/acs.jmedchem.6b01389","article-title":"Benzenesulfonamides incorporating flexible triazole moieties are highly effective carbonic anhydrase inhibitors: synthesis, kinetic, crystallographic, computational and intraocular pressure lowering investigations","volume":"59","author":"Nocentini","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0255","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1016\/j.bmc.2016.05.072","article-title":"N-Nitrosulfonamides: a new chemotype for carbonic anhydrase inhibition","volume":"24","author":"Nocentini","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.02.021_h0260","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/14756366.2017.1308928","article-title":"Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging","volume":"32","author":"Zhang","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818300518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818300518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:52:03Z","timestamp":1758613923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818300518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":52,"alternative-id":["S0045206818300518"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.02.021","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of novel pyrazoline-based aromatic sulfamates with potent carbonic anhydrase isoforms II, IV and IX inhibitory efficacy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}